Past Programs

Over its 14 years of operation, the Foundation for NIH has launched and guided hundreds of innovative programs to their successful completion, furthering the knowledge of scores of diseases and advancing science toward prevention, earlier diagnoses, therapies and cures.

Completed Programs, Past Programs

First described more than 100 years ago, Alzheimer’s disease (AD) has no cure or lasting, effective treatment. Currently, more than 5 million people in the United States suffer from it and its incidence is projected to increase dramatically over the next 20 years.

Completed Programs, Past Programs

Established in 1997, the Clinical Research Training Program (CRTP) is one of the Foundation for NIH’s premier public-private partnerships. With long-term support from Pfizer Inc, the program has enabled 280 of the country’s most promising medical and dental students to experience clinical research firsthand in an intensive, year-long, residential training program at the National Institutes of Health.

Completed Programs, Past Programs

One of the foundation’s earliest and largest capital programs, construction of the Edmond J. Safra Family Lodge was and is regarded as the anchor to our family-programs portfolio.

Completed Programs, Past Programs

In 2009, the many friends and family members of Dr. Stephen E. Straus contributed over $15,000 to the Foundation for NIH to commission a portrait of Dr. Straus, the founding director of the National Center for Complementary and Alternative Medicine (NCCAM).  

Completed Programs, Past Programs

Families of patients with serious illness endure great stress in caring for and supporting their loved one undergoing care at the NIH Clinical Center.

Completed Programs, Past Programs

The Best Pharmaceuticals for Children Act of 2002 provided for the testing of drugs that had been approved for adult use and that are used to treat children, but had not been tested for children.

Completed Programs, Past Programs

This project, made possible by $650,000 in private-sector contributions to the Foundation for NIH, was overseen by the National Cancer Institute.

Completed Programs, Past Programs

The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is NIH’s largest public-private partnership on brain research.

Completed Programs, Past Programs

Through the foundation, Action to Cure Kidney Cancer (ACKC) sponsored a postdoctoral candidate’s kidney cancer research in the laboratory of Dr. Richard Childs at The National Heart Lung and Blood Institute (NHLBI).

Completed Programs, Past Programs

In 2007, the Genetic Association Information Network (GAIN) completed an ambitious program to genotype existing research studies in six major common diseases, and combine the results with clinical data to create a significant new resource for genetic researchers.

Completed Programs, Past Programs

The Minority Faculty-Student Partnership (MFSP) Traineeships in Biotechnology was a program of the National Institutes of Health and the Foundation for Advanced Education in the Sciences, Inc.

Completed Programs, Past Programs

To best benefit the hundreds of thousands of patients who rely upon life-sustaining kidney dialysis, this program supports the implementation of randomized clinical trials of daily in-center and home hemodialysis.

Completed Programs, Past Programs

This program provides a model for teaching increased physical activity and good nutritional practices to children with disabilities. Children participating in the eight-week program are provided with a mentor who trains them and provides guidance on healthy living and behaviors. Students who have completed the program are awarded The Presidential Active Lifestyle Award certificate.

Completed Programs, Past Programs

Melanoma is the most aggressive form of skin cancer. In 2009, there were nearly 69,000 estimated new cases of melanoma in the United States.

Completed Programs, Past Programs

The Avon-NCI Progress for Patients Awards Program, completed in 2009, made a significant impact on breast cancer research, accelerating the movement of pre-clinical discoveries to application in patients, and fostering collaborative efforts that optimized resources and efficiencies.

Completed Programs, Past Programs

The goal of this multi-year project is to evaluate schizophrenia medications as they relate to indicators for cardiovascular disease and disease stability, and to determine treatment effectiveness.